Clarity Medical Group Holding Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Clarity Medical Group Holding şirketinin kazançları yıllık ortalama -69.5% oranında azalırken, Healthcare sektörünün kazançları yıllık 11.2% oranında artan oldu. Gelirler yıllık ortalama 1.3% oranında azalan oldu.

Anahtar bilgiler

-69.5%

Kazanç büyüme oranı

-75.8%

EPS büyüme oranı

Healthcare Sektör Büyümesi	11.3%
Gelir büyüme oranı	-1.3%
Özkaynak getirisi	-40.0%
Net Marj	-39.7%
Son Kazanç Güncellemesi	31 Mar 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Here's Why We're Watching Clarity Medical Group Holding's (HKG:1406) Cash Burn Situation

Aug 14

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Mar 21

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Dec 26

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Aug 16

Gelir ve Gider Dağılımı

Clarity Medical Group Holding nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SEHK:1406 Gelir, gider ve kazançlar (HKD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
31 Mar 24	191	-76	89
31 Dec 23	199	-53	94
30 Sep 23	208	-31	99
30 Jun 23	211	-17	91
31 Mar 23	214	-3	83
31 Dec 22	215	4	75
30 Sep 22	215	11	67
30 Jun 22	220	12	69
31 Mar 22	225	13	70
31 Mar 21	222	36	61
31 Mar 20	218	26	56
31 Mar 19	207	30	47

Kaliteli Kazançlar: 1406 şu anda kârlı değil.

Büyüyen Kar Marjı: 1406 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 1406 kârlı değildir ve zararlar son 5 yılda yılda 69.5% oranında artmıştır.

Büyüme Hızlandırma: 1406 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 1406 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( -16.9% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: 1406 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -39.99% ) sahiptir.

Clarity Medical Group Holding Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Recent updates

Clarity Medical Group Holding Limited Announces CEO Changes

Here's Why We're Watching Clarity Medical Group Holding's (HKG:1406) Cash Burn Situation

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

New major risk - Revenue size

New minor risk - Share price stability

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Clarity Medical Group Holding Limited, Annual General Meeting, Sep 20, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

New minor risk - Financial data availability

Clarity Medical Group Holding Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Year Ended 31 March 2023

Executive Director recently bought HK$589k worth of stock

Investor sentiment improves as stock rises 16%

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Non-Executive Director exercised options to buy HK$4.5m worth of stock.

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Now 24% undervalued after recent price drop

Less than half of directors are independent

Clarity Medical Group Holding Limited to Report First Half, 2023 Results on Nov 28, 2022

Clarity Medical Group Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2022

Investor sentiment improved over the past week

Executive Director recently bought HK$110k worth of stock

Investor sentiment deteriorated over the past week

Executive Director recently bought HK$59k worth of stock

Executive Director recently bought HK$735k worth of stock

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Executive Director recently bought HK$166k worth of stock

Clarity Medical Group Holding Limited Announces Executive Changes

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 26, 2022

Clarity Medical Group Holding Limited to Report Fiscal Year 2022 Results on Jun 28, 2022

Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022

Executive Director recently sold HK$1.3m worth of stock

Less than half of directors are independent

Executive Director recently sold HK$378k worth of stock

Investor sentiment improved over the past week

Executive Director recently sold HK$58k worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought HK$7.6m worth of stock

Clarity Medical Group Holding Limited has completed an IPO in the amount of HKD 217.6 million.

Less than half of directors are independent

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin